The DCPS Knockout HCT 116 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HCT 116 human colorectal carcinoma cell line, engineered to disrupt the expression of the DCPS gene. This knockout tool provides a reliable cell-based model for investigating the biological functions of the DCPS scavenger decapping enzyme within the context of mRNA decay and surveillance pathways. The polyclonal knockout format offers a robust population-level loss-of-function model without the need for single-cell clone isolation. CRISPR/Cas9-mediated gene disruption ensures efficient targeting of DCPS, enabling researchers to study the global consequences of compromised mRNA cap hydrolysis in a genetically defined background.
HCT 116 cells are a widely used human epithelial colon cancer cell line harboring an activating KRAS mutation, making them a relevant model for studying colorectal carcinoma biology. These cells display characteristic features of transformed epithelial cells, including rapid proliferation and susceptibility to apoptosis upon stress. The HCT 116 background has been extensively characterized in cancer research, including studies of signal transduction, drug response, and genomic integrity. Utilization of HCT 116 as the host cell line allows the investigation of DCPS-mediated mRNA turnover mechanisms in a malignant context, potentially uncovering connections between mRNA surveillance defects and tumorigenesis.
DCPS encodes the scavenger decapping enzyme that hydrolyzes the residual 7-methylguanosine cap structure on mRNA intermediates following 3??-5?? exonucleolytic degradation by the cytoplasmic exosome complex. This decapping activity is essential for complete mRNA turnover and is tightly coupled with the 5??-3?? decay machinery. DCPS functions downstream of the exosome and interacts directly with the Lsm1-7 complex, which bridges the decapping step with subsequent 5??-3?? degradation by XRN1 exonuclease. The enzyme is also subject to regulation by upstream factors including the MYC and TP53 transcription factors, as well as by cellular stress signaling pathways that coordinate mRNA stability. In the context of the HCT 116 knockout, disruption of DCPS leads to accumulation of capped mRNA fragments, impairing normal mRNA surveillance and potentially triggering nonsense-mediated mRNA decay (NMD) pathways. The DCPS protein interacts with multiple components of the mRNA decay machinery, including exosome subunits EXOSC3, EXOSC10, and DIS3, and its activity is critical for preventing the buildup of toxic mRNA decay intermediates.
In the HCT 116 colorectal carcinoma background, loss of DCPS function provides a unique opportunity to dissect the interplay between mRNA metabolism and cancer cell phenotypes. Accumulation of aberrant mRNA species may alter gene expression programs that control proliferation, apoptosis, or stress responses. Given that DCPS mutations are linked to human neurodevelopmental disorders such as intellectual disability and congenital anomalies, this knockout model also serves as a versatile platform for exploring the molecular basis of these conditions in a tractable cell culture system. The polyclonal knockout population allows assessment of bulk cellular responses without clonal variability, making it suitable for transcriptomic and proteomic analyses. Researchers can investigate how DCPS deficiency influences the turnover of specific oncogenic or tumor-suppressive transcripts in the KRAS-mutant background.
Typical applications include monitoring mRNA decay intermediates by Northern blotting or RT-qPCR, performing RNA-sequencing to globally identify transcriptome changes, and conducting Western blotting to confirm DCPS protein loss. The knockout cells are valuable for studying the cellular response to chemotherapeutic agents that may intersect with RNA metabolism, as well as for screening small-molecule inhibitors targeting the decapping enzyme. Functional assays such as cell proliferation and apoptosis assays can delineate the impact of DCPS loss on cancer cell fitness. Additionally, immunofluorescence can be used to assess the subcellular localization of mRNA decay factors in the absence of DCPS. For more information about DCPS Knockout HCT 116 Polyclonal Cells, please contact Ascent Research.
